ALLO - CIK 0001737287
Allogene Therapeutics, Inc. has filed 558 documents with the SEC between 2018 and 2026. The most frequent type is insider trade (234 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2023-12-19 | 2023-12-09 |
| Insider sale notice | 144 | 2023-12-18 | - |
| Company correspondence | CORRESP | 2023-12-15 | - |
| SEC correspondence | UPLOAD | 2023-11-21 | - |
| Quarterly report | 10-Q | 2023-11-02 | 2023-09-30 |
| Major company event | 8-K | 2023-11-02 | 2023-11-02 |
| Prospectus supplement | 424B5 | 2023-11-02 | - |
| Activist ownership stake (update) | SC 13D/A | 2023-10-25 | - |
| Major company event (amended) | 8-K/A | 2023-10-17 | 2023-10-16 |
| Insider trade | 4 | 2023-10-17 | 2023-10-16 |
| Major company event | 8-K | 2023-10-16 | 2023-10-16 |
| New insider ownership | 3 | 2023-10-16 | 2023-10-16 |
| Insider trade | 4 | 2023-08-17 | 2023-08-14 |
| New insider ownership | 3 | 2023-08-17 | 2023-08-14 |
| Insider trade | 4 | 2023-08-14 | 2023-08-10 |
| New insider ownership | 3 | 2023-08-14 | 2023-08-10 |
| Insider trade | 4 | 2023-08-09 | 2023-08-07 |
| Insider sale notice | 144 | 2023-08-07 | - |
| Quarterly report | 10-Q | 2023-08-02 | 2023-06-30 |
| Major company event | 8-K | 2023-08-02 | 2023-08-02 |
| Passive ownership stake | SC 13G | 2023-07-10 | - |
| Insider sale notice | 144 | 2023-06-29 | - |
| Major company event | 8-K | 2023-06-21 | 2023-06-15 |
| Insider sale notice | 144 | 2023-06-20 | - |
| Major company event | 8-K | 2023-06-15 | 2023-06-13 |
| Insider trade | 4 | 2023-06-15 | 2023-06-13 |
| Insider trade | 4 | 2023-06-15 | 2023-06-13 |
| Insider trade | 4 | 2023-06-15 | 2023-06-13 |
| Insider trade | 4 | 2023-06-15 | 2023-06-13 |
| Insider trade | 4 | 2023-06-15 | 2023-06-13 |
| Insider trade | 4 | 2023-06-15 | 2023-06-13 |
| Insider trade | 4 | 2023-06-15 | 2023-06-13 |
| Major company event | 8-K | 2023-06-14 | 2023-06-09 |
| Insider sale notice | 144 | 2023-06-12 | - |
| Major company event | 8-K | 2023-06-07 | 2023-06-03 |
| Quarterly report | 10-Q | 2023-05-03 | 2023-03-31 |
| Major company event | 8-K | 2023-05-03 | 2023-05-03 |
| Insider trade | 4 | 2023-04-26 | 2023-04-24 |
| New insider ownership | 3 | 2023-04-26 | 2023-04-24 |
| Annual report to shareholders | ARS | 2023-04-24 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-04-24 | - |
| Proxy statement | DEF 14A | 2023-04-24 | - |
| Major company event | 8-K | 2023-04-20 | 2023-04-18 |
| Insider trade | 4 | 2023-04-05 | 2023-04-01 |
| New insider ownership | 3 | 2023-04-05 | 2023-04-01 |
| Insider trade | 4 | 2023-03-24 | 2023-03-22 |
| Insider trade | 4 | 2023-03-24 | 2023-03-22 |
| Insider trade | 4 | 2023-03-24 | 2023-03-22 |
| Insider trade | 4 | 2023-03-24 | 2023-03-22 |
| Insider trade | 4 | 2023-03-24 | 2023-03-22 |